Showing results (51-60 of 123) with videos related to
Sort By:
Pageof 13
American Journal of Clinical Oncology|March 24, 2010
Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreasJean-Claude M Rwigema, Simul D Parikh, Dwight E Heron, et al.Journal of Surgical Oncology|August 20, 2013
Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancerBrian A Boone, Jennifer Steve, Alyssa M Krasinskas, et al.Annals of Surgical Oncology|August 6, 2014
Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenocarcinomaBrian A Boone, Jennifer Steve, Mazen S Zenati, et al.BMC Evolutionary Biology|November 14, 2007
Functional evolution of the vitamin D and pregnane X receptorsErica J Reschly, Afonso Celso Dias Bainy, Jaco Joaquim Mattos, et al.Molecular Vision|December 5, 2008
Repeated, noninvasive, high resolution spectral domain optical coherence tomography imaging of zebrafish embryosLarry Kagemann, Hiroshi Ishikawa, Jian Zou, et al.Clinical and Translational Science|May 18, 2021
SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinomaNaomi Fei, Sijin Wen, Rajesh Ramanathan, et al.Annals of Surgical Oncology|December 4, 2019
Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic CancerPranav Murthy, Mazen S Zenati, Amr I Al Abbas, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 22, 2021
The Role of Adjuvant Chemotherapy Following Right Hemicolectomy for Non-metastatic Mucinous and Nonmucinous Appendiceal AdenocarcinomaSamer S AlMasri, Alessandro Paniccia, Abdulrahman Y Hammad, et al.The American Journal of Surgical Pathology|May 18, 2013
Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosisDouglas J Hartman, Marina N Nikiforova, Daniel T Chang, et al.Annals of Surgical Oncology|November 25, 2010
Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancerPhilip Q Bao, Ramesh K Ramanathan, Alyssa Krasinkas, et al.Pageof 13